Drug Information

Drug General Information
Drug ID
D0OK9X
Former ID
DCL000477
Drug Name
AZD6765
Drug Type
Small molecular drug
Indication Major depressive disorder [ICD9: 296.2, 296.3, 710.0; ICD10:F32, F33, M32] Discontinued in Phase 2 [542661], [548584]
Company
AstraZeneca
Formula
C13H14N2
InChI
InChI=1S/C13H14N2/c14-13(11-6-2-1-3-7-11)10-12-8-4-5-9-15-12/h1-9,13H,10,14H2/t13-/m0/s1
InChIKey
FWUQWDCOOWEXRY-ZDUSSCGKSA-N
PubChem Compound ID
9794203
PubChem Substance ID
14748660, 15219981, 24104555, 44830222, 53112938, 103615523, 127910984, 143117003, 162222329, 198938400, 223366016, 223519242, 225983122, 227635317
Target and Pathway
Target(s) NMDA receptor Target Info Antagonist [550288]
References
Ref 542661(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7681).
Ref 548584Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026805)
Ref 550288Clinical pipeline report, company report or official report of AstraZeneca (2009).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.